[1] |
Walling HW, Sontheimer RD. Cutaneous lupus erythematosus[J].Am J Clin Dermatol, 2009,10(6):365⁃381. doi: 10.2165/11310 780⁃000000000⁃00000.
|
[2] |
靳慧, 赵明, 陆前进.红斑狼疮患者1 006例临床特征研究:来自中国人群红斑狼疮多中心病例对照研究[J]. 中华皮肤科杂志, 2016,49(1):6⁃11. doi: 10.3760/cma.j.issn.0412⁃4030.2016. 01.002.
|
[3] |
Sticherling M, Bonsmann G, Kuhn A. Diagnostic approach and treatment of cutaneous lupus erythematosus[J]. J Dtsch Dermatol Ges, 2008,6(1):48⁃59. doi: 10.1111/j.1610⁃0387.2007.06557.x.
|
[4] |
赵辨. 中国临床皮肤病学[M]. 南京: 江苏科学技术出版社, 2009:789⁃806.
|
[5] |
中华医学会皮肤性病学分会免疫学组. 皮肤型红斑狼疮诊疗指南[J]. 临床皮肤科杂志, 2012,41(6):390⁃392. doi: 10.3969/j.issn.1000⁃4963.2012.06.032.
|
[6] |
Kuhn A, Aberer E, Bata⁃Csörgő Z, et al. S2k guideline for treatment of cutaneous lupus erythematosus⁃guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)[J]. J Eur Acad Dermatol Venereol, 2017,31(3):389⁃404. doi: 10.1111/jdv.2017.31.issue⁃3.
|
[7] |
Sandholdt LH, Laurinaviciene R, Bygum A. Proton pump inhibitor⁃induced subacute cutaneous lupus erythematosus[J]. Br J Dermatol, 2014,170(2):342⁃351. doi: 10.1111/bjd.2014.170.issue⁃2.
|
[8] |
He Y, Sawalha AH. Drug⁃induced lupus erythematosus: an update on drugs and mechanisms[J]. Curr Opin Rheumatol, 2018,30(5):490⁃497. doi: 10.1097/BOR.0000000000000522.
|
[9] |
Kuhn A, Kuehn E, Meuth AM, et al. Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)[J]. Autoimmun Rev, 2009,8(8):702⁃712. doi: 10.1016/j.autrev.2009.02.022.
|
[10] |
张建中, 金江, 郭利劭, 等. 两型亚急性皮肤型红斑狼疮病情演变的分离现象[J]. 中华皮肤科杂志, 2001,34(1):9⁃11. doi:10.3760/j.issn:0412⁃4030.2001.01.001.
|
[11] |
Baltaci M, Fritsch P. Histologic features of cutaneous lupus erythematosus[J]. Autoimmun Rev, 2009,8(6):467⁃473. doi: 10. 1016/j.autrev.2008.12.014.
|
[12] |
中西医结合学会皮肤性病学专业委员会皮肤影像学亚专业委员会. 毛发疾病皮肤镜诊断专家共识[J]. 中国麻风皮肤病杂志, 2016,32(3):129⁃132.
|
[13] |
孙秋宁, 刘洁. 协和皮肤镜图谱[M]. 北京: 人民卫生出版社, 2015:161⁃162.
|
[14] |
Tao J, Zhang X, Guo N, et al. Squamous cell carcinoma complicating discoid lupus erythematosus in Chinese patients: review of the literature,1964-2010[J]. J Am Acad Dermatol,2012,66(4):695⁃696. doi: 10.1016/j.jaad.2011.09.033.
|
[15] |
李明, 孙建方. 结缔组织病皮肤表现图鉴与诊疗精要[M]. 北京: 北京大学医学出版社, 2009:1⁃29.
|
[16] |
史冬梅, 严红霞, 贾虹. 肿胀性红斑狼疮19例病例分析及文献回顾[J]. 实用皮肤病学杂志, 2015,39(5):332⁃335. doi: 10.11786/sypfbxzz.1674⁃1293.20150505.
|
[17] |
Vieira V, Del PJ, Yebra⁃Pimentel MT, et al. Lupus erythematosus tumidus: a series of 26 cases[J]. Int J Dermatol, 2006,45(5):512⁃517. doi: 10.1111/ijd.2006.45.issue⁃5
|
[18] |
廖文俊, 樊平申, 胡雪慧, 等. 红斑狼疮的皮肤组织病理学表现[J]. 临床皮肤科杂志, 2007,36(6):404⁃406. doi:10.3969/j.issn.1000⁃4963.2007.06.039.
|
[19] |
郑捷. 皮肤红斑狼疮的分型与诊断[J]. 诊断学理论与实践,2004,3(4):228⁃230. doi: 10.3969/j.issn.1671⁃2870.2004.04. 002.
|
[20] |
朱学骏, 涂平, 陈喜雪, 等. 皮肤病的组织病理学诊断[M]. 3版. 北京: 北京大学医学出版社, 2016:265⁃267.
|
[21] |
Hedrich CM, Fiebig B, Hauck FH, et al. Chilblain lupus erythematosus⁃a review of literature[J]. Clin Rheumatol, 2008,27(8):949⁃954. doi: 10.1007/s10067⁃008⁃0942⁃9.
|
[22] |
Jin H, Zhang G, Zhou Y, et al. Old lines tell new tales: Blaschko linear lupus erythematosis[J]. Autoimmun Rev, 2016,15(4):291⁃306. doi: 10.1016/j.autrev.2015.11.014.
|
[23] |
陈媛, 张芙蓉, 宋智琦, 等. 线状皮肤型红斑狼疮4例[J]. 中国皮肤性病学杂志, 2018,32(1):68⁃71. doi: 10.13735/j.cjdv.1001⁃7089.201703120.
|
[24] |
李明, 孙建方. 皮肤科结缔组织病诊治[M]. 北京: 北京大学医学出版社, 2017:29⁃36.
|
[25] |
陆前进, 张建中, 邓丹琪. 红斑狼疮:从基础到临床[M]. 北京: 北京大学医学出版社, 2013:141⁃158.
|
[26] |
Wu H, Huang X, Qiu H, et al. High salt promotes autoimmunity by TET2⁃induced DNA demethylation and driving the differenti⁃ation of Tfh cells[J]. Sci Rep, 2016,6:28065. doi: 10.1038/srep 28065.
|
[27] |
Chang J, Werth VP. Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects[J]. Expert Rev Clin Immunol, 2016,12(10):1109⁃1121. doi: 10.1080/1744 666X.2016.1188006.
|
[28] |
Bolognia JL, Jorizzo JL, Rapini RP. Dermatology[M]. 2nd ed. St. Louis (MO): Mosby Elsevier, 2008:561⁃574.
|
[29] |
Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus erythematosus: update of therapeutic options part I[J]. J Am Acad Dermatol,2011,65(6):e179⁃e193. doi: 10.1016/j.jaad.2010.06.018.
|
[30] |
Yokogawa N, Eto H, Tanikawa A, et al. Effects of hydroxychloroquine in patients with cutaneous lupus erythema⁃tosus: a multicenter, double⁃blind, randomized, parallel⁃group trial[J]. Arthritis Rheumatol, 2017,69(4):791⁃799. doi: 10.1002/ art.v69.4.
|
[31] |
Zhang FR, Liu H, Irwanto A, et al. HLA⁃B*13:01 and the dapsone hypersensitivity syndrome[J]. N Engl J Med, 2013,369(17):1620⁃1628. doi: 10.1056/NEJMoa1213096.
|